CPIX

Handel nachbörslich: 7.79

Cumberland Pharmaceuticals Inc (CPIX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Cumberland Pharmaceuticals Inc

Healthcare (1080)

615-255-0068

1600 WEST END AVENUE, NASHVILLE,, TN

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CPIX's Discussions on Twitter

Compare CPIX vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CPIX Cumberland Pharmaceuticals Inc	7.79	118.52M	41.94M	-7.40M	1.29M	-0.4935
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2012-11-12	Bestätigt	UBS	Neutral
2011-02-01	Bestätigt	UBS	Neutral
2010-12-16	Herabstufung	UBS	Buy → Neutral
2010-08-17	Herabstufung	Jefferies	Buy → Hold
2010-08-17	Bestätigt	Morgan Joseph	Buy
2010-08-17	Bestätigt	UBS	Buy
2010-05-14	Bestätigt	Morgan Joseph	Buy

Alle ansehen

Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten

Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)

Cumberland Pharmaceuticals Inc (CPIX)

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Compare CPIX vs TAK, TEVA, HLN, ZTS, UTHR

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten

Price to book forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView

Cumberland Pharmaceuticals: Pivot Into Drug Development Creates Risk, Opportunity (CPIX) - Seeking Alpha

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - marketbeat.com

Cumberland Pharmaceuticals (CPIX) Slips 1.04% as Shares Test Key Support Near $7.22Volume Profile - dars.gov.et

Cumberland Pharmaceuticals (CPIX) Stock Cools As Cash Rich Biotech Pivot Begins - Sahm

Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ... - Yahoo Finance

Earnings call transcript: Cumberland Pharmaceuticals swings on Q2 2026 reset - Investing.com

Cumberland Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat

Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction - TradingView

Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Quarterly Earnings Results - MarketBeat

Cumberland Pharmaceuticals posts $4.1 million Q2 loss after Apotex deal - Quiver Quantitative

Cumberland Pays $1.50 Dividend After Apotex Brand Sale - Stock Titan

Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ... By GuruFocus - Investing.com Canada

ETFs Investing in Cumberland Pharmaceuticals Inc. Stocks - TradingView

Possible Generic Drug Tariffs and 2 Microcaps - TradingView

Cumberland Pharmaceuticals Q2 Results: Company update and earnings call set for Aug 4 - scanx.trade

Cumberland Pharmaceuticals Inc (CPIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

CPIX|Cumberland Pharmaceuticals Inc|Price:7.030|Chg%:+0.420 - TradingKey

Cumberland Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:CPIX - TradingView

TradingKey - TradingKey

Cumberland Pharmaceuticals Inc (CPIX) Institutional Confidence - TradingKey

Cumberland Pharmaceuticals Inc (CPIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Cumberland Pharmaceuticals Inc (CPIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Cumberland Pharmaceuticals Inc - TradingKey

CPIX|Cumberland Pharmaceuticals Inc|Price:6.610|Chg%:-0.375 - TradingKey

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat

Cumberland Pharmaceuticals | 8-K: Current report - Moomoo

Cumberland Pharmaceuticals declares $1.50 dividend - MSN

Cumberland Pharmaceuticals Inc. (CPIX) Gains Momentum, Approaches Key Resistance LevelNHNL Divergence - po-news-eg.net

Cumberland Pharma Board of Directors Has Authorized and Declared a Special Cash Div of $1.50 a Shr >CPIX - Moomoo

ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? - The Globe and Mail

BRIEF-Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share - Dailyhunt

Cumberland Pharmaceuticals 8-K Filing July 2026: Key Company Details, Stock Info, and Address on NASDAQ CPIX - Minichart

Cumberland Pharmaceuticals Announces Special Dividend, Share Buyback - TipRanks

Cumberland Pharmaceuticals declares $1.50 special dividend, $5M buyback after $100M Apotex deal - TradingView

Cumberland Pharmaceuticals (Nasdaq: CPIX) returns cash after $100M Apotex deal - Stock Titan

Cumberland Pharmaceuticals Inc. (CPIX) Stock: Unveils Special Dividend While Advancing Ifetroban Rare Disease Pipeline - parameter.io

Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 - marketscreener.com

Press Release: CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - Moomoo

/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./ - Yahoo Finance

Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share - TradingView

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - TradingView

Cumberland Pharmaceuticals (CPIX) Sees Modest Decline, Tests Key Support ZonePercent Above MA - dars.gov.et

Cumberland outlines new product expansion and sees $8.3M Q3 revenues while advancing clinical pipeline - MSN

Cumberland Pharmaceuticals (CPIX) Plunges Over 10% as Selling Pressure IntensifiesTriangle Correction - dars.gov.et

Cumberland Pharmaceuticals (CPIX) Slides 11.6%: Testing Key Support Near $5.98ETH Profile - dars.gov.et

Cumberland Pharmaceuticals Sells Branded Drug Portfolio to Apotex for $100M, Refocuses on Rare Disease Pipeline 1 - Minichart

CPIXCumberland Pharmaceuticals Inc Latest SEC Filings - Finviz

Cumberland Refocuses on Rare Disease Pipeline After Asset Sale - TipRanks

Cumberland (CPIX) nets $100M from Apotex deal, shifts to rare disease pipeline - Stock Titan

Cumberland Pharmaceuticals closes $100 million sale of drug portfolio - The Business Journals

Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CPIX